Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Protheroe

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Nature Clinical Practice. Oncology|November 3, 2005
Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?Andrew Protheroe
Postgraduate Medical Journal|October 6, 2007
Testis cancerOmar Khan, Andrew Protheroe
Anti-Cancer Drugs|September 4, 2008
Cisplatin-associated thrombosisMariam Jafri, Andrew Protheroe
Oncotargets and Therapy|December 10, 2020
Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to DateEliana M C Tacconi, Mark Tuthill, Andrew Protheroe
Expert Review of Anticancer Therapy|August 1, 2012
Recent advances in urinary bladder cancer detectionJaimin Bhatt, Nigel Cowan, Andrew Protheroe, et al.
Histopathology|September 24, 2011
Blastic plasmacytoid dendritic cell neoplasm presenting as a renal massIsha Prematilleke, Vivek Mohan, Ian Roberts, et al.
Expert Review of Anticancer Therapy|September 13, 2019
Tumor heterogeneity: does it matter?Casmir Turnquist, Robert A Watson, Andrew Protheroe, et al.
Clinical Chemistry and Laboratory Medicine|January 6, 2018
Abiraterone acetate: a potential source of interference in testosterone assaysBenjamin P Fairfax, Robert D Morgan, Andrew Protheroe, et al.
Urologic Oncology|December 8, 2009
An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinibThinn P Pwint, Valentine Macaulay, Ian S D Roberts, et al.
BMC Cancer|October 19, 2019
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinomaKarin Purshouse, Sarah Chamberlain, Maria Soares, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Nature Clinical Practice. Oncology|November 3, 2005
Does docetaxel plus prednisone prolong the survival of men with metastatic hormone-refractory prostate cancer?Andrew Protheroe
Postgraduate Medical Journal|October 6, 2007
Testis cancerOmar Khan, Andrew Protheroe
Anti-Cancer Drugs|September 4, 2008
Cisplatin-associated thrombosisMariam Jafri, Andrew Protheroe
Oncotargets and Therapy|December 10, 2020
Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to DateEliana M C Tacconi, Mark Tuthill, Andrew Protheroe
Expert Review of Anticancer Therapy|August 1, 2012
Recent advances in urinary bladder cancer detectionJaimin Bhatt, Nigel Cowan, Andrew Protheroe, et al.
Histopathology|September 24, 2011
Blastic plasmacytoid dendritic cell neoplasm presenting as a renal massIsha Prematilleke, Vivek Mohan, Ian Roberts, et al.
Expert Review of Anticancer Therapy|September 13, 2019
Tumor heterogeneity: does it matter?Casmir Turnquist, Robert A Watson, Andrew Protheroe, et al.
Clinical Chemistry and Laboratory Medicine|January 6, 2018
Abiraterone acetate: a potential source of interference in testosterone assaysBenjamin P Fairfax, Robert D Morgan, Andrew Protheroe, et al.
Urologic Oncology|December 8, 2009
An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinibThinn P Pwint, Valentine Macaulay, Ian S D Roberts, et al.
BMC Cancer|October 19, 2019
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinomaKarin Purshouse, Sarah Chamberlain, Maria Soares, et al.
Pageof 9